ELLENDALE GABBERT: Open Payments
NPI 1134337017 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 39 payments from 12 companies in 2025. Trend: 2023 $1,132 · 2024 $628 · 2025 $680
Food & beverage: $680
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $166 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $92 |
| Amgen Inc. | 4 | $68 |
| PFIZER INC. | 3 | $59 |
| Boston Scientific Corporation | 1 | $41 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| SCPHARMACEUTICALS INC. | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Cleerly, Inc. | 1 | $18 |
Products named: LEQVIO, LifeVest, ELIQUIS, REPATHA, WATCHMAN, VERQUVO, CAMZYOS, FUROSCIX.
Industry payments across LA — which companies pay providers there.
